<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04617678</url>
  </required_header>
  <id_info>
    <org_study_id>CTR Prehab HN</org_study_id>
    <nct_id>NCT04617678</nct_id>
  </id_info>
  <brief_title>A Comprehensive Approach to Head and Neck Cancer Prehabilitation</brief_title>
  <official_title>A Comprehensive Approach to Head and Neck Cancer Prehabilitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanford Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of North Dakota</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sanford Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Head and neck cancer accounts for 3% of malignancies in the United States. However, the&#xD;
      diagnosis and treatment for head and neck cancer is considered to be debilitating. Not&#xD;
      because of its morbidity, but due to the extremely rigorous treatment course which has a&#xD;
      profound impact on patients physical, social, and emotional functioning. Disfigurement and&#xD;
      sensorimotor deficits further compound this impact. Head and neck cancer patients contend&#xD;
      with treatments that can significantly affect their quality of life. Treatment regularly&#xD;
      results in decreased functional capacity and decreased quality of life. Physical impairments&#xD;
      are manifested through, but not limited to, disfigurement, deconditioning, communication&#xD;
      issues, &quot;swallowing, speech, breathing, and cancer-related fatigue&quot;. Premorbid factors such&#xD;
      as preexisting anxiety and depression, chemical dependency, financial barriers, and lack of&#xD;
      social support system are unique obstacles to the head and neck cancer population impacting&#xD;
      treatment and outcomes. Due to these factors, patients experience higher rates of anxiety and&#xD;
      depression, psychological distress, and fear of cancer recurrence. In fact, &quot;compared with&#xD;
      other survivors of cancer, head and neck cancer survivors are almost 2 times more likely to&#xD;
      die from suicide&quot;. In view of the aforementioned research, Roger Maris Cancer Center's head&#xD;
      and neck cancer will implement a prehabilitation program that evaluates each patient using&#xD;
      standardized screening tools and provide personalized education and interventions. This&#xD;
      project evaluates a more comprehensive and proactive multidisciplinary approach to improve&#xD;
      treatment and outcomes in head and neck cancer patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective Arm compared to Retrospective Control Arm</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Study Completion</measure>
    <time_frame>6 months post treatment</time_frame>
    <description>Subject has completed all study visits</description>
  </primary_outcome>
  <other_outcome>
    <measure>Nutrition Focused Physical Exam</measure>
    <time_frame>pre-treatment, 8 weeks post treamtment, 6 months post treatment</time_frame>
    <description>Subjects will have a nutrition focused physical exam during the study</description>
  </other_outcome>
  <other_outcome>
    <measure>Behavioral Health Screen</measure>
    <time_frame>pre-treatment, 8 weeks post treamtment, 6 months post treatment</time_frame>
    <description>Subjects will complete Behavioral Health Screen - 6 questionnaires during the study. Scores are from 0 (better outcome) to 3 (worse outcome)</description>
  </other_outcome>
  <other_outcome>
    <measure>Columbia Suicide Severity Rating Scale</measure>
    <time_frame>pre-treatment, 8 weeks post treamtment, 6 months post treatment</time_frame>
    <description>Subjects will complete Columbia Suicide Severity Rating Scale questionnaires during the study. Questions are Yes (worse outcome) or No (better outcome) answers.</description>
  </other_outcome>
  <other_outcome>
    <measure>Sarcopenia</measure>
    <time_frame>pre-treatment, 8 weeks post treamtment, 6 months post treatment</time_frame>
    <description>Subjects will complete Bioelectric Impedance Spectroscopy during the study</description>
  </other_outcome>
  <other_outcome>
    <measure>National Comprehensive Cancer Network Distress Thermometer</measure>
    <time_frame>pre-treatment, 8 weeks post treamtment, 6 months post treatment</time_frame>
    <description>Subjects will complete National Comprehensive Cancer Network Distress Thermometer questionnaires during the study. Scale is from 0 (better outcome) to 10 (worse outcome).</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Cancer of Head and Neck</condition>
  <arm_group>
    <arm_group_label>Prospective Prehabilitation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Prospectively enrolling patients into a prehabilitation program for head and neck cancer.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Retrospective Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Retrospectively comparing patients that did not enroll into the prehabilitation program for head and neck cancer.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Prehabilitation Program</intervention_name>
    <description>We will assess whether prehabilitation intervention helps mitigate adverse symptoms (e.g., anxiety, depression, suicidality, distress, nutritional status, dysphagia, sarcopenia, and well-being) on a sample of head and neck cancer patients. Subjects will attend a Prepare for Surgery Heal Faster session and meet with a physical therapist, registered dietician, speech language pathologist, and masters of social work at pre-treatment, 6-8 weeks post-treatment, and 5-6 months post-treatment completion.</description>
    <arm_group_label>Prospective Prehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Equal to or greater than 18 years of age&#xD;
&#xD;
          -  Diagnosis of Oral Cavity Cancer, Pharyngeal Cancer, Laryngeal Cancer Stages I-IV&#xD;
&#xD;
          -  Actively pursuing cancer treatment with a curative intent&#xD;
&#xD;
          -  Willing and able to provide written consent&#xD;
&#xD;
          -  Capable of giving signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with cardiac arrhythmia with pacemaker&#xD;
&#xD;
          -  Patients with other implanted electronic equipment/device&#xD;
&#xD;
          -  Patients undergoing external defibrillation&#xD;
&#xD;
          -  Pregnant women (per BIS instructions for use, pregnant women should not participate)&#xD;
&#xD;
          -  Patient weight exceeding 375 lbs.&#xD;
&#xD;
          -  Patient has a metal allergy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cheryl Hysjulien, PsyD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sanford Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy Schmidt, RN</last_name>
    <phone>(701) 234-7667</phone>
    <email>amy.schmidt@sanfordhealth.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sanford Health</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58104</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Elizabeth Eidenschink</last_name>
      <phone>701-234-6298</phone>
      <email>Elizabeth.Eidenschink@SanfordHealth.org</email>
    </contact>
    <investigator>
      <last_name>Cheryl Hysjulien, PsyD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Samuel SR, Maiya AG, Fernandes DJ, Guddattu V, Saxena PUP, Kurian JR, Lin PJ, Mustian KM. Effectiveness of exercise-based rehabilitation on functional capacity and quality of life in head and neck cancer patients receiving chemo-radiotherapy. Support Care Cancer. 2019 Oct;27(10):3913-3920. doi: 10.1007/s00520-019-04750-z. Epub 2019 Mar 27.</citation>
    <PMID>30919154</PMID>
  </reference>
  <reference>
    <citation>Stenson, K. M. (2019). Epidemiology and risk factors for head and neck cancer. UpToDate. Retrieved, November 15, 2019 from https://www.uptodate.com/contents/epidemiology-and-risk-factors-for-head-and-neck-cancer.</citation>
  </reference>
  <reference>
    <citation>Osazuwa-Peters N, Simpson MC, Zhao L, Boakye EA, Olomukoro SI, Deshields T, Loux TM, Varvares MA, Schootman M. Suicide risk among cancer survivors: Head and neck versus other cancers. Cancer. 2018 Oct 15;124(20):4072-4079. doi: 10.1002/cncr.31675. Epub 2018 Oct 18.</citation>
    <PMID>30335190</PMID>
  </reference>
  <reference>
    <citation>Beck ACC, Passchier E, Ret√®l VP, Stuiver MM, van der Molen L, Klop WMC, Navran A, van Harten WH, van den Brekel MWM. Study protocol of a prospective multicenter study comparing (cost-)effectiveness of a tailored interdisciplinary head and neck rehabilitation program to usual supportive care for patients treated with concomitant chemo- or bioradiotherapy. BMC Cancer. 2019 Jul 3;19(1):655. doi: 10.1186/s12885-019-5874-z.</citation>
    <PMID>31269918</PMID>
  </reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 23, 2020</study_first_submitted>
  <study_first_submitted_qc>October 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2020</study_first_posted>
  <last_update_submitted>November 4, 2020</last_update_submitted>
  <last_update_submitted_qc>November 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

